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Introduction. Human tuberculosis is a contagious-infectious disease mainly caused by 
Mycobacterium tuberculosis. Although regimens exist for treating tuberculosis, they are far from 
ideal. Development of effective strategies for treatment of human tuberculosis has posed a 
challenge, considering the increase in infections associated with the human immunodeficiency 
virus and immunocompromised patients. Essential oils -volatile, aromatic oil extracts from plants-
have been used in traditional treatment of many diseases; however careful investigation of these 
oils has not been undertaken with respect to treatments of tuberculosis. 
Objective. The in vitro antitubercular activity of essential oils from 11 medicinal plants grown in 
Colombia were assessed for efficacy as new medications (phytomedicines) for treatment of M. 
tuberculosis H37Rv.
Material and methods. Essential oil extraction and analysis were performed as described 
Stashenko et al. (2004). Minimal inhibitory concentrations were determined by a colorimetric 
macrodilution method, following the protocol described by Abate et al. (1998).  Isoniazide and 
rifampin were used as control treatments.  Bactericidal and bacteriostatic activity was measured 
using the method developed by the Clinical and Laboratory Standards Institute consigned in the 
M26-A protocol.
Results. Essential oils from Achyrocline alata and Swinglea glutinosa were the most active with 
minimal inhibitory concentrations of 62.5±0.1 and 100±36 µg ml-1, respectively. Carvacrol, thymol, 
p-cymene, 1,8-cineole, limonene, and β-pinene were the major components ,most often identified 
in the 11 plant extracts of essential oils. Time-kill curve assays demonstrated the bacteriostatic 
activity of these essential oils. 
Conclusions. The essential oils from A. alata and S. glutinosa plants, and the  components 
identified therein, are candidates as potential phytotherapeutic agents for human tuberculosis 
control.
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Actividad antituberculosa de plantas colombianas
Introducción. La tuberculosis es una enfermedad infectocontagiosa causada por Mycobacterium 
tuberculosis. Aunque existen protocolos para su tratamiento, no son ideales. Actualmente, el 
desarrollo de estrategias terapéuticas efectivas ha tomado nuevos rumbos, considerando 
el incremento de pacientes positivos para el virus de la inmunodeficiencia humana. Los 
medicamentos basados en plantas medicinales se usan ampliamente en la medicina tradicional 
para el tratamiento de diversas afecciones. Los aceites esenciales obtenidos de plantas 
medicinales presentan amplia actividad antimicrobiana, sin embargo, existen pocos estudios que 
reporten la actividad antituberculosa de los mismos.
Objetivo. Evaluar la actividad antituberculosa in vitro de 11 aceites esenciales provenientes de 
plantas medicinales que crecen en Colombia, los cuales podrían ser candidatos para el desarrollo 
de futuros fitofármacos.
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Materiales y métodos. La extracción y el análisis de los aceites esenciales se realizó bajo 
la metodología desarrollada por Stashenko et al.. La obtención de la concentración inhibitoria 
mínima se llevó a cabo por un método colorímetrico de macrodilución en caldo descrito por 
Abate y et al.; la isoniacida y la rifampicina se usaron como medicamentos control. La actividad 
bactericida y bacteriostática se determinaron mediante el protocolo M26-A del Clinical and 
Laboratory Standards Institute.
Resultados. Los aceites esenciales provenientes de las plantas Achyrocline alata y Swinglea 
glutinosa fueron los más activos con concentraciones inhibitorias mínimas de 62,5±0,01 y 100±36 
µg ml-1, respectivamente. Carvacrol, timol, p-cymene, 1,8-cineole, limoneno, y β-pineno fueron 
los componentes mayoritarios identificados en los 11 aceites. Los ensayos de curva de letalidad 
evidenciaron que ambos aceites son bacteriostáticos.
Conclusiones. Los aceites esenciales obtenidos de las plantas A. alata y S. glutinosa, así 
como sus componentes, son candidatos potenciales como fitoterapéuticos para el control de la 
tuberculosis. 
Palabras clave: Mycobacterium tuberculosis, tuberculosis, agentes antiinfecciosos, plantas 
medicinales, fitoterapia, Colombia
Human tuberculosis (TB) is a contagious infec-
tious disease mainly caused by Mycobacterium 
tuberculosis.  It is an aerobic pathogenic bacterium 
that usually establishes its infection in the lungs 
(1). About one third of the world’s population is 
currently infected with M. tuberculosis. Fully 10% 
of those infected will develop clinical disease, 
particularly those who also have the human 
immunodeficiency virus (HIV) infection. TB is 
the leading cause of death worldwide from a 
single  pathogen, claiming more adult lives than 
diseases AIDS, malaria, diarrhea, leprosy, and all 
other tropical diseases combined (2). The World 
Health Organization (WHO) estimates that active 
cases of tuberculosis afflict seven to eight million 
people annually, and lead up to three million 
deaths per year (3).
Although regimens exist for treating tuberculosis, 
they are far from ideal. Treatment usually involves 
a combination of the drugs isoniazid (INH) and 
rifampin (RMP), which must be administered for 
at least six months, or a combination of pyra-
zinamide and ethambutol (EMB) (or streptomycin), 
which are used only in the first two months 
of treatment (4). Because adherence to this 
regimen is extremely difficult, WHO recommends 
a program of directly observed treatment, short-
course (DOTS), in which health care workers 
watch as each  patient ingests the medicine (4). 
Approximately 21% of the world’s TB patients 
were treated under DOTS in 1998. Therefore, 
inconsistent or partial treatment is common and 
has led to the development and spread of drug-
resistant strains. Consequently,  shorter, simpler 
therapeutic and prophylactic regimens must be 
developed to increase adherence. In addition, 
new drugs are necessary to combat the increasing 
number of multi-drug-resistant TB strains (MDR-
TB) and extensively drug-resistant (XDR-TB) 
strains. A greater understanding of the molecular 
mechanisms of drug action and drug resistance 
will assist and promote the development of newer 
compounds (1,4).
Plant-based drugs have been used worldwide 
in traditional medicines for the treatment of a 
variety of diseases. Approximately 60% of the 
world population relies on medicinal plants for its 
primary healthcare. These medicinal plant species 
serve as a rich source of many  biologically active 
compounds, although very few plant species have 
been thoroughly investigated for their medicinal 
properties (5). Interest in phytomedicine has been 
renewed during the last decade and now, many 
medicinal plant species are being screened for 
pharmacological activities (6). Aromatic plants 
have been used since ancient times for their 
preservative and medicinal properties, as well as 
to impart aroma and flavor to food. Hippocrates, 
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the ‘father of medicine’, prescribed aromatic 
fumigations (7).
The pharmaceutical properties of aromatic plants 
are partially attributed to essential oils. Essential 
oils are natural, complex, multi-component systems 
composed mainly of terpenes along with a few non-
terpene components (7). The ancient Egyptians 
used aromatic plants in embalming to stop 
bacterial growth and prevent decay, an effect 
largely attributed to their essential oil content. 
Strong in vitro evidence indicates that essential 
oils can act as antibacterial agents against a wide 
spectrum of pathogenic bacterial strains (7). Some 
terpenes, such as citronellol, nerol and geraniol 
have shown moderate antimycobacterial activity 
(8). The aim of the present study is to evaluate the 
antimycobacterial activity of essential oils derived 
from 11 species of aromatic and medicinal plants, 
grown in Colombia.  If effective, these substances 
pose as potential candidates for the development 
of new medication for treatment of TB.
Material and Methods
Plant material
The voucher numbers, the geographic region of 
plant collection, vernacular names and botanical 
names are listed in Table 1. The taxonomic 
identification of the botanical species was 
performed by José Luis Fernández at Herbario 
Nacional de Colombia, Natural Sciences Institute, 
Faculty of Sciences, Universidad Nacional de 
Colombia, Bogotá; where desiccated samples of 
each plant remain as permanent vouchers.
Essential oils extraction
The essential oils were extracted from a 300 g 
sample of plant leaves and stems by microwave-
assisted hydrodistillation (30 min, 250 mL water), 
using a Clevenger-type distillation apparatus 
and a Dean-Stark distillation trap in a domestic 
microwave oven (Kendo, MO-124, 2.5 GHz, 
800 W)  (9). Sodium sulfate (Merck, Darmstadt, 
Germany) was added as a drying agent to the 
decanted essential oil.
Essential oils analysis
An aliquot (50 µL) of each essential oil, along 
with the internal standard (n-tetradecane, 4 µL) 
was dissolved in dichloromethane to reach a final 
volume of 1.0 mL. For chromatographic analysis, 
1.0 µL of this solution was injected into an Agilent 
Technologies 6890 Plus gas chromatograph 
(Agilent Technologies, Palo Alto, CA, USA.), 
equipped with an Agilent Technologies 5973N 
mass selective detector, a split/splitless injector 
(split ratio 1:50), a 7863 automatic injector, and 
a MSChemStation G1701-DA data system. 
The available spectral libraries included the 
WILEY 138K, NIST 2002 and QUADLIB 2004. 
A fused-silica capillary column DB-5MS (J&W 
Scientific, Folsom, CA, USA) of 60 mm x 0.25 
mm I.D. x 0.25 µm df, was employed. The oven 
temperature was programmed from 45°C (5 min) 
to 150°C (2 min) at 4 °C min-1, then to 250°C 
(5 min) at 5 °C min-1, and finally, to 275°C (15 
min) at 10°C min-1. The ionization chamber and 
transfer line temperatures were kept at 230°C 
and 285°C, respectively. Compound identification 
was based on comparisons with standard terpenic 
compounds by (1) chromatographic (Kovàts 
indices) criteria and (2) spectroscopic data and 
their comparison with known standards and with 
extant databases.
Antimycobacterial activity
The essential oil antimycobacterial activity was 
evaluated according to the macrodilution protocol, 
described by Abate et al. (1998) (10). The M. 
tuberculosis H37Rv strain (ATCC 27294) was 
cultured at 37°C in Lowestein-Jensenn medium 
until log phase growth; then a cell suspension was 
prepared at a concentration of about 2x106 UFC 
mL-1 and further diluted 1:20 in Middlebrook 7H9 
(Becton Dickinson and Co., Sparks MD, USA) 
medium. The later was supplemented with 10% 
OADC (oleic acid-albumin-dextrose-catalase) 
(Becton Dickinson and Co., Sparks MD, USA) 
and 0.001% Tween 80 (Sigma, New Jersey, 
USA).  One mL of the bacterial suspension was 
added to each tube (capped, glass) together 
with the diluted essential oils diluted.  The final 
concentrations of the essential oils ranged from 
31.25 to 500 µg ml-1 and adjusted to a final 2 
mL-volume. After a 7-day incubation, 100 µL of 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) (5 mg mL-1) (Sigma, New Jersey, 
USA) with 20% Tween 80 (Sigma, New Jersey, 
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Table 1. Plant information, main compounds and minimum inhibitory concentration (MIC, µg ml-1) against M. tuberculosis H37Rv, of the essential 
oils studied.
Sample Botanical Collection Vernacular namea Part of the plant Essential oil main MICb ± sc, µg ml-1
N° name site and used for essential compounds (nd = 3)
    Voucher number oil extraction and oil 
     yield 
 
1 Lippia origanoides Pedregal, Orégano de monte” Leaves and stems; 1. Thymol (54.5%)
 (Fam.  Nariño COL.520285, “ 3.1% 2. p-Cymene (10.0%)
 Verbenaceae)  Thymol  3. γ-Terpinene (5.0%)
   chemotype  4. Thymyl acetate (4.8%)
     5. β-Myrcene (2.8%)
     6. trans-β-Caryophyllene (2.4%) 125 ± 0.01
     7. Methyl thymyl esther (1.9%)
     8. Carvacrol (1.7%)
     9. α-Terpinene (1.6%) 
      10. α-Humulene (1.5%) (14) 
2 Cananga odorata Bucaramanga,  “Ylang-ylang”, Fresh, fully mature 1. Linalool (20.7%)
 Fam.  Santander introduced to yellow flowers; 2. Benzyl acetate (20.6%)
 Annonaceae)  Colombia,  1.2% 3. Benzyl benzoate (14.2%)
   presumably from   4. Germacrene D (10.2%)
   Philippines  5. p-Methyl anisole (6.8%)
     6. Cinnamyl acetate (5.1%)  300 ± 217  
     7. Geranyl acetate (2.9%)
      8. α-Humulene (2.8%) 
      9. (E,E)-Franesene (2.4%)
      10. Benzyl salicylate (2.3%) (15, 16)
3 Swinglea glutinosa Bucaramanga,  “Limón africano”, Fruit peel; 1. β-Pinene (49.6%)
 (Fam. Rutaceae) Santander introduced to 0.7% 2. α-Pinene (12%)
   Colombia,  3. Sabinene (11.0%)
   COL.521530  4. Bicyclosesquiphellandrene (8.1%)
      5. Limonene (4.4%)
      6. 1,8-Cineol (3.0%) 100 ± 36
      7. Terpinen-4-ol (2.7%)
      8. trans-β-Caryophyllene (1.5%)
      9. γ-Terpinene (1.4%) 
      10. α-Terpineol (1.2%) (18)
4 Hyptis mutabilis Villavicencio, “Mastranto” Leaves and stems; 1. Fenchone (17.1%)
 (Fam. Lamiaceae))  Meta COL.512275 0.3% 2. 1,8-Cineol (12.6%) 
     3. trans-β-Caryophyllene (10.9%)
      4. Bicyclogermacrene (8.7%)
      5. Germacrene D (6.2%)
      6. Limonene (4.8%)
      7. α-Pinene (3.8%) 125 ± 0.01
      8. β-Pinene (3.7%)
      9. β-Boubonene (3.4%)
      10. Spathulenol (3.0%)
5 Piper auritum Cali, “Anisillo” Leaves; 1. Safrol (91.3%)
 (Fam. Piperaceae) Valle del Cauca COL.512209 2.3% 2. Myristine (4.8%)
     3. Methyl eugenol (0.8%)
      4. α-Terpinolene (0.6%)
      5. γ-Terpinene (0.5%)
      6. p-Cymene (0.2%) 400 ± 220
      7. trans-β-Caryophyllene (0.3%)
      8. Eugenol (0.2%)
      9. Elemicine (0.2%)
      10. Spathulenol (0.2%) 
6 Lippia origanoides Los Santos, “Orégano de monte¨, Leaves and stems; 1.trans-β-Caryophyllene (11.3%)
 (Fam. Verbenaceae) Santander COL.516294, 1.5% 2. p-Cymene (11.2%)
   Caryophyllene  3. α-Phellandrene (9.9%)
   chemotype  4. Limonene (7.2%) 
     5. 1,8-Cineol (6.5%)
     6. α-Humulene (6.0%)
      7. Borneol (3.1%) 400 ± 220
°
Biomédica 2009;29:51-60
55
Anti-tubercular activity of Colombian medicinal plants
      8. Camphene (2.6%)
      9. α-Pinene (2.3%)
      10. Caryophyllene oxide (2.2%) (15)
7 Achyrocline alata Nariño “Viravira” Leaves and stems; 1. Thymol (24.0%), 
 (Fam. Asteraceae) Potosí, COL.519601 0.3% 2. trans-β-Caryophyllene (13.3%), 
     3. p-Cymene (3.2%), 
      4. α-Pinene (2.6%),
      5. α-Humulene (2.4%), 
      6. Thymyl acetate (2.3%), 
      7. Viridiflorene (2.3%),  62.5±0.01 
    8. Caryophyllene oxide (2.2%), 
      9. α-Bisabolol (1.7%).
      10. α-Eudesmol (1.6%) 
8 Lippia origanoides Piedecuesta, “Orégano de monte¨, Leaves and stems; 1. Carvacrol (46.2%)
 (Fam. Verbenaceae) Santander COL.516290, 4.4% 2. p-Cymene (12.0%)  
   Carvacrol  3. Thymol (9.9%)
   chemotype  4. γ-Terpinene (9.5%) 
      5. α-Terpinene (2.7%)
      6. β-Myrcene (2.5%)
      7. trans-β-Caryophyllene (2.0%) 160 ± 72
      8. α-Thujene (1.5%)
      9. α-Humulene (1.2%) 
      10. Terpinen-4-ol (1.1%) (15)
9 Lippia alba Venadillo, “Pronto alivio”, Leaves and stems; 1. Carvone (50.3%)
 (Fam. Verbenaceae) Tolima COL.520287 2.5% 2. Limonene (30.2%)
   Carvone  3. Piperitone (6.1%)
   chemotype  4. Bicyclosesquiphellandrene (3.5%)
     5. β-Bourbonene (1%)
      6. Piperitone (3.1%)
      7. β-Myrcene (0.8%) 200 ± 72
      8. Dihydrocarvone (0.8%)
      9. Carveol (0.8%)
      10. Cubebol (0.5%) (9) 
10 Piper bogotense Ipiales, “Matico” Leaves; 1. Sesquisabinene hydrate (14.2%)
 (Fam. Piperaceae) Nariño COL.519590 0.2% 2. α-Phellandrene (13.7%) 130 ± 95
     3. α-Pinene (8.7%)
      4. Limonene (5.3%)
      5. Linalool (4.7%)
      6. p-Cymene (4.4%)
      7. β-phellandrene (3.4%)
      8. δ-Cadinene (3.4%)
      9. α-Bisabolol (3.5%)
      10.trans-β-Caryophyllene (3.1%)
11 Lippia alba Bucaramanga, “Pronto alivio”, Leaves and stems; 1. Geranial (31.5%), 
 (Fam. Verbenaceae) Santander COL.512272 1.6% 2. Neral (23.8%), 
   Citral  3. Geraniol (7.9%), 
   Chemotype  4. trans-β-Caryophyllene (5.8%), 
     5. Geranyl acetate (3.6%), 
      6. Limonene (2.5%),  130 ± 95
      7. 6-Methyl-5-hepten-2-one (2.1%), 
      8. cis-Verbenol (1.9%), 
      9. trans-Verbenol (1.5%),
      10 α-Humulene (1.4%) (17) 
INH Isoniazid  -- -- -- -- 0.19±0.07
RIF Rifampin  -- -- -- -- 0.3±0.21
a – Vernacular name in Colombia
b Minimum Inhibitory Concentration (µg ml-1)
c Standard error of the mean
d Number of assays
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USA) was added to the glass tubes. A violet 
color indicated bacterial growth. The tubes were 
evaluated for color change on day 8. For standard 
tests, the MIC values of rifampin and isoniazid 
(Sigma, New Jersey, USA) were determined 
each time. The acceptable minimum inhibitory 
concentration (MIC) ranges of these drugs were 
0.50-0.03 µg ml-1, respectively. The MIC of each 
oil corresponded to the lowest concentration at 
which the bacteria tested did not show growth. 
Susceptibility testing was performed 3 times. The 
results were expressed as the mean of the three 
tests. Results were expressed as geometric 
mean (GM) ± standard error of the mean (s) of 
the MICs.
Antimycobacterial time kill curves
Time-kill curves were used to measure the 
bactericidal activity of essential oils with lowest 
MICs values. Bactericidal activity was measured in 
glass tubes, each containing 2 mL of Middlebrook 
7H9 (Becton Dickinson and Co., Sparks MD, 
USA) medium.  The medium was supplemented 
with 10% OADC (oleic acid-albumin-dextrose-
catalase) (Becton Dickinson and Co., Sparks MD, 
USA) and 0.001% Tween 80 (Sigma, New Jersey, 
USA) at concentrations 0,1-, 2-, and 5-fold above 
the respective MIC. The final concentration of 
mycobacteria was approximately 106 CFU mL-1. 
Samples were taken every two days until the sixth 
day and were serially diluted in sterile distilled 
water to avoid  significant carryover,  and then 
plated in Lowestein-Jensenn tubes with screw 
caps.  The tubes were incubated at 37°C in an 
Incubator Shaker Model G25 (New Brunswick 
Scientific Co, New Jersey, USA). Isoniazid and 
rifampin were used as control drugs. The time-
kill curve assay was done according to the 
recommendations of the Clinical and Laboratory 
Standards Institute (11).
Data analysis 
MICs results are expressed as geometric mean 
(GM) ± standard error of the mean (S.E.M). The 
results of kill-kinetic determinations are shown 
graphically by plotting log10 CFUs against time 
and expressed as mean ± standard error of the 
mean (S.E.M). A bactericidal effect can be seen 
by a 3 log10 (99.9% killing) decrease in CFU at 
the time specified.
Results
The results of the essential oil antimycobacterial 
screening and the composition of each oil are 
presented in table 1. All essential oils showed 
activity against Mycobacterium tuberculosis 
H37Rv. Only the Achyrocline alata essential 
oil exhibited a pronounced antimycobacterial 
activity below 100 µg ml-1 (62.5 µg ml-1). Other 
essential oils presented a moderate activity 
(MIC between 100 and 200 µg ml-1). The major 
components of essential oils evaluated are listed 
in table 1. Carvacrol, thymol, p-cymene, 1,8-cineole, 
limonene, and β-pinene were the most commonly 
identified, the major components of A. alata were 
thymol, trans-β-caryophyllene, p-cymene and 
α-phellandrene. Figure 1 shows the interaction 
between essential oils MIC and M. tuberculosis 
strain H37Rv. As shown, the A. alata essential oil 
possessed the lowest MIC, in comparison with 
the others.
The time kill curves of A. alata essential oils, 
Swinglea glutinosa essential oils and the control 
drugs isoniazid and rifampin are shown in the 
figures 2 to 5. In comparison with the bactericidal 
activity of isoniazid and rifampin at concentrations 
equivalent 0.5-fold above the respective MIC, the 
essential oils were bacteriostatic.
Discussion
Historicall, plants have been used worldwide in 
traditional medicines for the treatment of diseases. 
Today, approximately two-thirds to three-quarters 
of the world’s population are estimated to rely 
on medicinal plants as their primary source of 
medicines (12). The current study represents the 
first phase of ongoing research to identify new, 
safe and effective agents for the treatment of TB. 
Lippia origanoides and Lippia alba plants of the 
Verbenaceae family already have many ethno-
pharmacological applications. Both species 
possess several chemotypes (13,14). Cananga 
odorata (ylang-ylang) trees are an introduced 
species and have been widely distributed as 
ornamentals in Colombian cities. Ylang-ylang 
essential oil pharmacological effects have 
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Figure 2. Time kill curve of isoniazide against M. tuberculosis H37Rv. Values are reported as mean ± S.E.M. Concentrations 
at 0.5-, 1-, and 2-fold levels of the respective MIC indicate the bactericidal activity in comparison with the control.
Figure 1. Interaction between essential oils MIC with M. tuberculosis H37Rv. Values are reported as mean ± S.E.M. 
Achyrocline alata (sample 7) and Swinglea glutinosa (sample 3) produced MICs below 100 µg/mL. Isoniazide (INH) and 
rifampin (RIF) were used as controls.
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Figure 3. Time kill curve of rifampin against M. tuberculosis H37Rv. Values are reported as mean ± S.E.M. Concentrations at 
0.5-, 1-, and 2-fold above the respective MIC present bactericidal activity in comparison with the control.
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been thoroughly investigated (15-17). Swinglea 
glutinosa (Rutaceae family) is a shrub planted 
in cities and countryside as a natural fence.  Its 
extract is used in agriculture in natural prepa-
rations of biocides (18,19). Piper auritum and 
Piper bogotense of the family Piperaceae  are 
widely distributed in Colombia and serve a variety 
of applications in folk medicine.  Hyptis mutabilis 
(family Asteraceae) and Achyrocline alata (family 
Lamiaceae) play similar roles (20, 21).
Figure 5. Time kill curve of A. alata against M. tuberculosis H37Rv. Values are reported as mean ± S.E.M. Concentrations at 
0.5-, 1-, and 2-fold levels of the respective MIC indicate the bacteriostatic activity in comparison with the control.
Figure 4. Time kill curve of S. glutinosa against M. tuberculosis H37Rv. Values are reported as mean ± S.E.M. Concentrations 
at 0.5-, 1-, and 2-fold levels of the respective MIC indicate the bacteriostatic activity in comparison with the control.
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geraniol has been evaluated with MICs between 
64-128 µg ml-1 (8).
In many essential oils, the antimicrobial activity 
is due to the presence of isoprenes such as 
monoterpenes, sesquiterpenes or related alcohols 
and phenols (26). The lipophilic character of 
their hydrocarbon skeleton and the hydrophilic 
character of their functional groups are of 
main importance in the antimicrobial action 
of essential oil components (26) which have 
high antimicrobial and antifungal activities (26). 
Possibly, the antibacterial activity of terpenes is 
due to a perturbation of the microorganism lipid 
fraction of the plasma membrane, and results 
in alterations of membrane permeability and 
in leakage of intracellular materials (27). This 
effect may be a consequence of the interaction 
between the major and minority components 
of essential oil. It was demonstrated that the 
physical properties significantly influenced the 
actions of the individual components, increasing 
or reducing antimicrobial efficacy (26).
The essential oil concentrations decrease 
substantially in broth and agar media, when 
incubated under open conditions. This decrease 
is caused primarily by evaporation and adherence 
on plastic surfaces (28). For these reasons, broth 
dilution assays must be carried out under sealed 
conditions to prevent evaporative loss, and glass 
materials must be used in place of plastics to 
prevent loss by absorption. In the current study, 
the antimycobacterial assays performed by a 
macrodilution method in glass tubes corrected 
these problems and consequently reproducible 
results were obtained. In addition, the screening 
method permitted the detection of resistance by 
M. tuberculosis to INH, RMP and even for EMB 
(10,29).
Some authors use Tween 80 in the broth medium 
to enhance oil solubility (30). In the current study, 
MIC of Tween 80 against M. tuberculosis H37Rv 
determined in the antimycobacterial assay (0.99%) 
was much higher than the concentration used for 
solubilizing oil (0.001%). Therefore, the addition 
of Tween 80 to the culture medium did not alter 
the MIC values obtained.
The essential oils and their volatile components 
may provide an important source of new anti-
mycobacterial agents. Evaluations in checker-
board assays of the individual components and 
their interactions of A. alata and S. glutinosa 
essential oils are necessary in order to 
determinate the active principles and toxicity of 
these complex mixes. Performing the macrodilution 
method with capped glass tubes is an alternative 
tool for obtaining more reproducible MIC values 
by controlling the essential oil high volatility.
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